Immunohistochemical evaluation of PD-1/PD-L1 expression within the tumor microenvironment is believed to predict the response to PD-1/PD-L1 inhibitors; however, its predictive value is relatively weak. This evidence concerns the gene PDCD1 and neoplasm.